American Well Corp (AMWL) Stock Price Today
Aura AI Summary
Key Stats
- $152.38MMarket Cap
- -Volume
- HealthSector
- $9.9152W High
- $3.7852W Low
- -Typical Hold Time
- -$22.86MEnterprise Value
- -Div Yield
- -Trading Activity
Track American Well Corp (AMWL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, American Well Corp has traded between a low of $3.78 and a high of $9.91, highlighting its annual price range. Buy and sell American Well Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Most Recent News
Renewed U.S.-Iran tensions push oil prices up, impacting key economic sectors and confirming AI investment confidence.
Renewed hostilities between the U.S. and Iran, including attacks on commercial vessels in the Strait of Hormuz and reinstated U.S. sanctions on Iran, caused crude oil prices to rise sharply. This increase pressured economically sensitive sectors such...
Alamar Biosciences' NULISA platform featured in 140+ studies at AAIC 2026, advancing blood-based Alzheimer's biomarker detection.
Alamar Biosciences announced that its NULISA platform was prominently featured in over 140 scientific presentations at the 2026 Alzheimer's Association International Conference (AAIC) in London, highlighting its growing adoption in Alzheimer's resear...
Alamar Biosciences showcases over 140 presentations on blood-based Alzheimer's biomarkers at AAIC 2026.
Alamar Biosciences presented extensive data from its NULISA platform at the AAIC 2026 conference, highlighting advances in blood-based biomarkers for Alzheimer's detection and staging. The company emphasized new findings on eMTBR-Tau and BD-pTau217, ...